Real-time enrollment status for this chronic inflammatory demyelinating polyneuropathy clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 7:00 AM UTC
| NCT Number | NCT06858579 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inflammatory Demyelinating Polyneuropathy |
| Phase | PHASE3 |
| Target Enrollment | 256 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Dianthus Therapeutics |
| Last Updated on CT.gov | July 13, 2026 (6 days ago) |
As of July 19, 2026: Clinical trial NCT06858579 is currently recruiting participants. This phase3 study for chronic inflammatory demyelinating polyneuropathy is actively seeking new participants at 32 locations across the United States. The study is sponsored by Dianthus Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06858579 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06858579 was last updated 6 days ago (July 13, 2026). HelloStudys verifies this status automatically.